CrossrefInfokarte
Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2
Cancer Immunology, Immunotherapy · 2023-10 · 72 (10) · 3243-3257
DOI: 10.1007/s00262-023-03490-8 ↗Abstract
Kein Abstract verfügbar.
EUVIMED